| Gatiflox (gatifloxacin) / Orient Europharma |
NCT00347828: Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose |
|
|
| Unknown status | 4 | 40 | US | Moxifloxacin ophthalmic solution 0.5%, Gatifloxacin ophthalmic solution 0.3% | Ophthalmic Consultants of Boston, Allergan | Eye Infection, Infection | | 06/06 | | |
| Completed | 4 | | US | Gatifloxacin, Ketorolac LS, Pred Forte, Moxifloxacin, Nepafenac, EconoPred Plus | Innovative Medical | Cataract Surgery | | | | |
NCT00433225: Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation |
|
|
| Completed | 4 | | US | Prednisolone Acetate, Ketorolac 0.4%, Gatifloxacin 0.3% | Innovative Medical | Macula Thickening | | | | |
NCT00703313: Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators |
|
|
| Completed | 4 | 72 | US | 1.5% levofloxacin ophthalmic solution, 0.5% moxifloxacin hydrochloride ophthalmic solution, 0.3% gatifloxacin ophthalmic solution | Santen Inc. | Healthy | 06/08 | | | |
NCT00464438: A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis |
|
|
| Completed | 4 | 171 | US, Canada | gatifloxacin, Zymar®, moxifloxacin 0.5% eye drops, Vigamox® | Allergan | Bacterial Conjunctivitis | 09/08 | 09/08 | | |
NCT00874887: A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms |
|
|
| Completed | 4 | 66 | US, Canada | moxifloxacin 0.5% HCI ophthalmic solution, Vigamox®, gatifloxacin ophthalmic solution 0.3%, ZYMAR® | Allergan | Anti-biotic Resistance | 09/09 | 10/09 | | |
NCT00410891: Topical Antibiotics and Intravitreous Injections |
|
|
| Completed | 4 | 129 | US | gatifloxacin | Stanford University | Intravitreous, Injections | 12/09 | 12/09 | | |
| Completed | 4 | 60 | US | Zymar, gatifloxacin | Stanford University | Ophthalmic Surgery | 12/10 | 12/10 | | |
ChiCTR-TRC-12002693: Comparative Study of Human Aqueous Humor Levels of Gatifloxacin 0.3% Eye Gel, Gatifloxacin 0.3% and Levofloxacin 0.5% Ophthalmic Solution after Topical Dosing |
|
|
| Completed | 4 | 150 | | One drop of gatifloxacin 0.3% eye gel was administration ;One drop of gatifloxacin 0.3% ophthalmic solution ;One drop of levofloxacin 0.5% ophthalmic solution | Zhejiang University; Zhejiang University, Zhejiang Key Innovation Team Project of China (2009R50039); Zhejiang Key Laboratory Fund of China (2011E10006) | endoophthalmitis after cataract surgery | | | | |
NCT01421693: Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever |
|
|
| Completed | 4 | 300 | RoW | Ceftriaxone, Gatifloxacin | Oxford University Clinical Research Unit, Vietnam, University of Oxford, Patan Academy of Health Sciences, Nepal, Patan Hospital, Nepal, Civil Hospital, Nepal | Enteric Fever, Typhoid Fever | 07/14 | 01/15 | | |
NCT03578276: Prophylactic Treatment: Lessdropsâ„¢ vs Standard Drops Regimen |
|
|
| Completed | 4 | 35 | US | Pred-Gati-Brom, LessDrops, Prednisolone acetate 1% ophthalmic suspension, Gatifloxacin Ophthalmic, Bromfenac 0.075% Oph Solution | Carolina Eyecare Physicians, LLC, Science in Vision, Imprimis Pharmaceuticals, Inc. | Cataract | 12/19 | 12/19 | | |
